The abstract is read at the publisher; the summary is JClub's.
In Caenorhabditis elegans infection models, disc diffusion inhibition zones weakly and inconsistently correlate with host-protective antibiotic activity, with correlations ranging up to 0.49.
- Why it matters: Conventional disc diffusion susceptibility testing may not reliably forecast whether antibiotics protect an infected host, limiting how well in vitro rankings translate to functional efficacy.
- What they did: The study measured disc diffusion zone of inhibition for 42 antibiotics and screened 75 antibiotics in an automated C. elegans infection assay, comparing 26 shared antibiotics at 9.6 microgram/mL. Worm activity was tracked at 24, 48, and 72 h with infection, vehicle, health, and antibiotic-toxicity controls.
- The result: Across MRSA, Pseudomonas aeruginosa, and Clostridioides difficile, DDA–activity correlations were weak-to-moderate and pathogen- and time-dependent (e.g., Pearson’s r from -0.20 to 0.31 at 24 h; -0.009 to 0.49 at 48 h). Against C. difficile, imipenem had the largest zone (41 mm) but did not protect worms at 24 and 48 h, while tobramycin had a smaller zone (26 mm) yet showed the highest early worm activity, implying DDA profiles do not consistently predict in vivo protection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.